The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Research Report 2025
Synopsis
Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is a preventive biological product developed to protect pigs, particularly swine in the agricultural industry, from the PRRS virus. PRRS is a significant disease affecting pigs, causing reproductive issues in sows and respiratory problems in young and growing pigs. The vaccine is designed to stimulate the pig's immune system to recognize and defend against the PRRS virus, reducing the severity of the disease's impact and preventing its transmission within swine populations.
The global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market was valued at US$ 1128 million in 2023 and is anticipated to reach US$ 1533 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) include CNADC, Boehringer-Ingelheim, MSD Animal Health, Sinopharm, Ceva, Chengdu Tianbang Biological Products Co., Ltd., Tianjin Ruipu Biological Technology Co., Ltd., Qilu Animal Health and Guangdong Wens Dahuanong Biotechnology Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS).
Report Scope
The Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CNADC
Boehringer-Ingelheim
MSD Animal Health
Sinopharm
Ceva
Chengdu Tianbang Biological Products Co., Ltd.
Tianjin Ruipu Biological Technology Co., Ltd.
Qilu Animal Health
Guangdong Wens Dahuanong Biotechnology Co., Ltd.
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tiankang
Zoetis
Guangdong Yongshun Biological Pharmaceutical Co Ltd
Plec Bioengineering Co., Ltd.
Segment by Type
Live Vaccine
Inactivated Vaccine
Segment by Application
Government Tender
Marketing
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is a preventive biological product developed to protect pigs, particularly swine in the agricultural industry, from the PRRS virus. PRRS is a significant disease affecting pigs, causing reproductive issues in sows and respiratory problems in young and growing pigs. The vaccine is designed to stimulate the pig's immune system to recognize and defend against the PRRS virus, reducing the severity of the disease's impact and preventing its transmission within swine populations.
The global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market was valued at US$ 1128 million in 2023 and is anticipated to reach US$ 1533 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) include CNADC, Boehringer-Ingelheim, MSD Animal Health, Sinopharm, Ceva, Chengdu Tianbang Biological Products Co., Ltd., Tianjin Ruipu Biological Technology Co., Ltd., Qilu Animal Health and Guangdong Wens Dahuanong Biotechnology Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS).
Report Scope
The Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CNADC
Boehringer-Ingelheim
MSD Animal Health
Sinopharm
Ceva
Chengdu Tianbang Biological Products Co., Ltd.
Tianjin Ruipu Biological Technology Co., Ltd.
Qilu Animal Health
Guangdong Wens Dahuanong Biotechnology Co., Ltd.
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tiankang
Zoetis
Guangdong Yongshun Biological Pharmaceutical Co Ltd
Plec Bioengineering Co., Ltd.
Segment by Type
Live Vaccine
Inactivated Vaccine
Segment by Application
Government Tender
Marketing
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Overview
1.1 Product Overview and Scope of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
1.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type
1.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Value Comparison by Type (2024-2030)
1.2.2 Live Vaccine
1.2.3 Inactivated Vaccine
1.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application
1.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Value by Application: (2024-2030)
1.3.2 Government Tender
1.3.3 Marketing
1.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Estimates and Forecasts
1.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2019-2030
1.4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2019-2030
1.4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competition by Manufacturers
2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price by Manufacturers (2019-2024)
2.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Product Type & Application
2.7 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competitive Situation and Trends
2.7.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players Market Share by Revenue
2.7.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario by Region
3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region: 2019-2030
3.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region: 2019-2024
3.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region: 2025-2030
3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region: 2019-2030
3.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region: 2019-2024
3.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region: 2025-2030
3.4 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.4.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2019-2030)
3.4.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.5.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2019-2030)
3.5.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2019-2030)
3.6.3 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.7.1 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2019-2030)
3.7.3 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2019-2030)
4.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2019-2024)
4.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2025-2030)
4.1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2019-2030)
4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2019-2030)
4.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2019-2024)
4.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2025-2030)
4.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2019-2030)
4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2019-2030)
5.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2019-2024)
5.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2025-2030)
5.1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2019-2030)
5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2019-2030)
5.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2019-2024)
5.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2025-2030)
5.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2019-2030)
5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CNADC
6.1.1 CNADC Corporation Information
6.1.2 CNADC Description and Business Overview
6.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.1.5 CNADC Recent Developments/Updates
6.2 Boehringer-Ingelheim
6.2.1 Boehringer-Ingelheim Corporation Information
6.2.2 Boehringer-Ingelheim Description and Business Overview
6.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.2.5 Boehringer-Ingelheim Recent Developments/Updates
6.3 MSD Animal Health
6.3.1 MSD Animal Health Corporation Information
6.3.2 MSD Animal Health Description and Business Overview
6.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.3.5 MSD Animal Health Recent Developments/Updates
6.4 Sinopharm
6.4.1 Sinopharm Corporation Information
6.4.2 Sinopharm Description and Business Overview
6.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.4.5 Sinopharm Recent Developments/Updates
6.5 Ceva
6.5.1 Ceva Corporation Information
6.5.2 Ceva Description and Business Overview
6.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.5.5 Ceva Recent Developments/Updates
6.6 Chengdu Tianbang Biological Products Co., Ltd.
6.6.1 Chengdu Tianbang Biological Products Co., Ltd. Corporation Information
6.6.2 Chengdu Tianbang Biological Products Co., Ltd. Description and Business Overview
6.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.6.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Developments/Updates
6.7 Tianjin Ruipu Biological Technology Co., Ltd.
6.6.1 Tianjin Ruipu Biological Technology Co., Ltd. Corporation Information
6.6.2 Tianjin Ruipu Biological Technology Co., Ltd. Description and Business Overview
6.6.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments/Updates
6.8 Qilu Animal Health
6.8.1 Qilu Animal Health Corporation Information
6.8.2 Qilu Animal Health Description and Business Overview
6.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.8.5 Qilu Animal Health Recent Developments/Updates
6.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
6.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Corporation Information
6.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Description and Business Overview
6.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
6.10 CAVAC
6.10.1 CAVAC Corporation Information
6.10.2 CAVAC Description and Business Overview
6.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.10.5 CAVAC Recent Developments/Updates
6.11 Komipharm
6.11.1 Komipharm Corporation Information
6.11.2 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.11.5 Komipharm Recent Developments/Updates
6.12 Agrovet
6.12.1 Agrovet Corporation Information
6.12.2 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.12.5 Agrovet Recent Developments/Updates
6.13 Bioveta
6.13.1 Bioveta Corporation Information
6.13.2 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.13.5 Bioveta Recent Developments/Updates
6.14 Jinyu Bio-Technology
6.14.1 Jinyu Bio-Technology Corporation Information
6.14.2 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.14.5 Jinyu Bio-Technology Recent Developments/Updates
6.15 Phibro Animal Health
6.15.1 Phibro Animal Health Corporation Information
6.15.2 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.15.5 Phibro Animal Health Recent Developments/Updates
6.16 Tiankang
6.16.1 Tiankang Corporation Information
6.16.2 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.16.5 Tiankang Recent Developments/Updates
6.17 Zoetis
6.17.1 Zoetis Corporation Information
6.17.2 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.17.5 Zoetis Recent Developments/Updates
6.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd
6.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Corporation Information
6.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments/Updates
6.19 Plec Bioengineering Co., Ltd.
6.19.1 Plec Bioengineering Co., Ltd. Corporation Information
6.19.2 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
6.19.5 Plec Bioengineering Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Chain Analysis
7.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Mode & Process
7.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Marketing
7.4.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Channels
7.4.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors
7.5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers
8 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Dynamics
8.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends
8.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Drivers
8.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
8.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Product Type & Application
Table 12. Global Key Manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2019-2024) & (K Units)
Table 18. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2019-2024)
Table 19. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2025-2030) & (K Units)
Table 20. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2025-2030)
Table 21. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2019-2024)
Table 23. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2025-2030)
Table 25. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2019-2024) & (K Units)
Table 27. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2025-2030) & (K Units)
Table 28. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Type (2019-2024)
Table 51. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Type (2025-2030)
Table 52. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2019-2024)
Table 53. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2025-2030)
Table 54. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2019-2024)
Table 57. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2025-2030)
Table 58. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Type (2019-2024)
Table 59. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Type (2025-2030)
Table 60. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Application (2019-2024)
Table 61. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Application (2025-2030)
Table 62. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2019-2024)
Table 63. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2025-2030)
Table 64. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2019-2024)
Table 67. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2025-2030)
Table 68. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Application (2019-2024)
Table 69. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Application (2025-2030)
Table 70. CNADC Corporation Information
Table 71. CNADC Description and Business Overview
Table 72. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 74. CNADC Recent Developments/Updates
Table 75. Boehringer-Ingelheim Corporation Information
Table 76. Boehringer-Ingelheim Description and Business Overview
Table 77. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 79. Boehringer-Ingelheim Recent Developments/Updates
Table 80. MSD Animal Health Corporation Information
Table 81. MSD Animal Health Description and Business Overview
Table 82. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 84. MSD Animal Health Recent Developments/Updates
Table 85. Sinopharm Corporation Information
Table 86. Sinopharm Description and Business Overview
Table 87. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 89. Sinopharm Recent Developments/Updates
Table 90. Ceva Corporation Information
Table 91. Ceva Description and Business Overview
Table 92. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 94. Ceva Recent Developments/Updates
Table 95. Chengdu Tianbang Biological Products Co., Ltd. Corporation Information
Table 96. Chengdu Tianbang Biological Products Co., Ltd. Description and Business Overview
Table 97. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 99. Chengdu Tianbang Biological Products Co., Ltd. Recent Developments/Updates
Table 100. Tianjin Ruipu Biological Technology Co., Ltd. Corporation Information
Table 101. Tianjin Ruipu Biological Technology Co., Ltd. Description and Business Overview
Table 102. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 104. Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments/Updates
Table 105. Qilu Animal Health Corporation Information
Table 106. Qilu Animal Health Description and Business Overview
Table 107. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 109. Qilu Animal Health Recent Developments/Updates
Table 110. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Corporation Information
Table 111. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Description and Business Overview
Table 112. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 114. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
Table 115. CAVAC Corporation Information
Table 116. CAVAC Description and Business Overview
Table 117. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 119. CAVAC Recent Developments/Updates
Table 120. Komipharm Corporation Information
Table 121. Komipharm Description and Business Overview
Table 122. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 124. Komipharm Recent Developments/Updates
Table 125. Agrovet Corporation Information
Table 126. Agrovet Description and Business Overview
Table 127. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 129. Agrovet Recent Developments/Updates
Table 130. Bioveta Corporation Information
Table 131. Bioveta Description and Business Overview
Table 132. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 134. Bioveta Recent Developments/Updates
Table 135. Jinyu Bio-Technology Corporation Information
Table 136. Jinyu Bio-Technology Description and Business Overview
Table 137. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 139. Jinyu Bio-Technology Recent Developments/Updates
Table 140. Phibro Animal Health Corporation Information
Table 141. Phibro Animal Health Description and Business Overview
Table 142. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 144. Phibro Animal Health Recent Developments/Updates
Table 145. Tiankang Corporation Information
Table 146. Tiankang Description and Business Overview
Table 147. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 149. Tiankang Recent Developments/Updates
Table 150. Zoetis Corporation Information
Table 151. Zoetis Description and Business Overview
Table 152. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 154. Zoetis Recent Developments/Updates
Table 155. Guangdong Yongshun Biological Pharmaceutical Co Ltd Corporation Information
Table 156. Guangdong Yongshun Biological Pharmaceutical Co Ltd Description and Business Overview
Table 157. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 159. Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments/Updates
Table 160. Plec Bioengineering Co., Ltd. Corporation Information
Table 161. Plec Bioengineering Co., Ltd. Description and Business Overview
Table 162. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 164. Plec Bioengineering Co., Ltd. Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
Table 168. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers List
Table 169. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Trends
Table 170. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Drivers
Table 171. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
Table 172. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Figure 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Type in 2023 & 2030
Figure 4. Live Vaccine Product Picture
Figure 5. Inactivated Vaccine Product Picture
Figure 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Application in 2023 & 2030
Figure 8. Government Tender
Figure 9. Marketing
Figure 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size (2019-2030) & (US$ Million)
Figure 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (2019-2030) & (K Units)
Figure 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price (US$/Unit) & (2019-2030)
Figure 14. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Report Years Considered
Figure 15. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Manufacturers in 2023
Figure 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players: Market Share by Revenue in 2023
Figure 18. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2019-2030)
Figure 21. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2019-2030)
Figure 22. United States Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2019-2030)
Figure 25. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2019-2030)
Figure 26. Germany Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2019-2030)
Figure 33. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2019-2030)
Figure 43. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2019-2030)
Figure 53. Global Revenue Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2019-2030)
Figure 54. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2019-2030)
Figure 56. Global Revenue Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2019-2030)
Figure 57. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Application (2019-2030)
Figure 58. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Value Chain
Figure 59. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
